- Investing Ideas
- Italian Healthcare Undervalued based on future growth
Italian Healthcare Undervalued based on future growth
Results
2
1 new
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
2 companies
GVS
Market Cap: €637.9m
Produces and sells filter solutions for applications in the healthcare and life sciences, energy and mobility, and health and safety sectors in Italy and internationally.
New
GVS
€3.41
7D
-0.7%
1Y
-29.6%
Svas Biosana
Market Cap: €43.0m
SVAS Biosana S.p.A. engages in the production and marketing of medical devices worldwide.
SVS
€8.10
7D
-0.5%
1Y
11.7%